Candesartan improved plasma HMW-ADN and PAI-1 values but not those of plasma Hs-CRP, VACM-1 and U-8-OHdG in hypertensive patients with type 2 diabetes mellitus of long duration independently of blood pressure changes. This evidence concerns the gene MAP3K14 and type 2 diabetes mellitus.